🔗 Visit the ClinicalTrials.gov page for NCT02191878
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Clinical experiences with systemically administered siRNA-based therapeutics in cancer. | Nat Rev Drug Discov | 2015 | 1.02 |
| 2 | Preclinical and clinical development of siRNA-based therapeutics. | Adv Drug Deliv Rev | 2015 | 1.01 |
| 3 | Clinical prospects of long noncoding RNAs as novel biomarkers and therapeutic targets in prostate cancer. | Prostate Cancer Prostatic Dis | 2015 | 0.97 |
| 4 | Drug development: try and try again. | Nature | 2014 | 0.88 |
| 5 | Production and clinical development of nanoparticles for gene delivery. | Mol Ther Methods Clin Dev | 2016 | 0.82 |
| 6 | Lipid nanoparticles for targeted siRNA delivery - going from bench to bedside. | Int J Nanomedicine | 2016 | 0.78 |
| 7 | Current development of targeted oligonucleotide-based cancer therapies: Perspective on HER2-positive breast cancer treatment. | Cancer Treat Rev | 2016 | 0.76 |